Wednesday, November 6, 2024
Owens & Minor (OMI) had been flying under Wall Street’s radar until it preannounced earnings this week. The medical supplies provider told the market it is essentially doubling its previous adjusted net income guidance. OMI raised projections for net income from $0.50 to $0.60 for the year to between $1.00 and $1.20. OMI said it […]
Electric vehicles have been all the rage lately in the stock and options market. NIO (NIO) has been no exception to this. The company is sometimes called the “Tesla of China” and actually has $1 billion worth of sales already. However, the huge run up in the stock price gave NIO an extremely high valuation, […]
Let’s dream for a moment. It’s November 2021. A coronavirus vaccine for was found in late December 2020. Due to pre-ramping of production facilities, 100% of the U.S. population has been vaccinated. COVID-19 is no more. Given this possible reality, where are you going to do your holiday shopping? Are you geared up for Black […]
Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]
The financial news focuses on the major stock market indexes. These are the Dow Jones Industrial Average (DJIA), the S&P 500, and the NASDAQ Composite Index (NASDAQ). However, the effects of the coronavirus pandemic on different sectors of the economy has these indexes painting an incomplete picture of what’s happening in the U.S. stock market. […]
In a year of unpredictable market action, perhaps the most eye-opening moves are occurring in electric vehicle (EV) stocks. EV companies like TSLA are all the rage right now. Just about any stock that has some relationship to electric vehicles sees a ton of action (in the stock and the options). Just look at what […]
It’s a puzzle that’s haunted Wall Street for a few years now: what the heck happened to value investing? Value investing was the strategy that long occupied the minds of Wall Street’s best stock-pickers. From Warren Buffett to Ben Graham to Peter Lynch, the focus was always on value investing. All prudent investors needed to […]
All after the company said its potential COVID-19 vaccine produced a “robust” immune response in all 45 patients in an early stage human trial. “These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost […]
If you are an income-focused investor, you likely feel that your investments have been left behind. The financial news covers the hot stocks such as Amazon and Tesla, which seem to set new record highs every day. Outside of the handful of top tech stocks, most investments have not recovered from the February and March […]
Vaxart, Inc. (VXRT) has moved substantially higher recently based on high hopes for the company’s COVID-19 vaccine. VXRT was chosen by the U.S. government for inclusion in Operation Warp Speed (OWS), the government’s national program with a goal of providing safe and effective vaccine doses by January of 2021. VXRT is one of a number […]
